UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000010259
Receipt number R000012008
Scientific Title A Phase II Study of Bi-weekly XELOX with Bevacizumab for patient with Metastatic Colorectal Cancer as first-line chemotherapy
Date of disclosure of the study information 2013/03/17
Last modified on 2022/03/28 08:22:30

No. Disposal Last modified on Item of update
1 Insert 2013/03/17 10:12:07
2 Update 2014/03/17 09:05:46 Last name of lead principal investigator
Last name of lead principal investigator
Email
Email
3 Update 2016/09/18 11:15:54 Name of primary person or sponsor
Organization
4 Update 2020/03/23 08:26:11 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
5 Update 2020/03/23 08:31:59 Date of IRB
Last follow-up date
6 Update 2022/03/28 08:22:30 Recruitment status
Last follow-up date